The frothy initial public offering (IPO) market is helping companies raise capital in the public market. According to data from BioWorld Snapshots, 18 IPOs of drug companies this year raised an aggregate of more than $1.3 billion. (See BioWorld Today, July 2, 2013.) Read More
In the short space of three months venture capital investing has demonstrated a remarkable turnaround. In the first quarter of 2013 the statistics revealed a drop in the value and volume of VC deals. The second quarter couldn't be more different. Read More
